Conference

Conference Details : 

Conference Date:	28th March 2025 – Friday
Time:	10 00 am – 5 00 pm
Venue:	Hall 4 & 5, Bharat Mandapam, New Delhi

𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗧𝗵𝗲𝗺𝗲 2025 :

Democratizing Diagnostics : The Domestic vs. Global Conundrum

This theme highlights the nuances, challenges, and approaches needed to address the needs of similar yet diverse markets.

Clinlab India 2025 Conference Objective :

The global In Vitro Diagnostics (IVD) market is experiencing steady growth, primarily driven by increasing prevalence of chronic diseases, rising demand for early diagnosis, and a growing adoption of advanced diagnostic technologies, solutions. The market size is projected to grow from approximately $80.85 billion in 2024 to over $157.56 billion by 2034, achieving a compound annual growth rate (CAGR) of 6.9% during this period.  

The market is also recovering from COVID-19 related disruptions, showing positive trends in core laboratory and Point-of-Care (POC), Home use testing (Self Testing) segments, with emerging markets poised for significant expansion. 

Growth Potential

Emerging markets, particularly in the Asia-Pacific (APAC), Latin America (LATAM), and parts of Eastern Europe, Africa, and the Middle East (EEMEA), present substantial opportunities for IVD companies.

Region-wise insights:

• Emerging markets: Significant potential for growth due to increasing healthcare spending and growing awareness about diagnostics. 

• Developed markets: Focus on innovation and adoption of advanced technologies in established healthcare systems. 

The global IVD sector is poised for robust growth, with emerging markets offering significant opportunities due to increasing healthcare demands and technological advancements. However, both emerging and advanced markets face challenges related to regulation, competition, and economic pressures. Strategic investments in innovation and compliance will be essential for companies aiming to thrive in this dynamic landscape.

Clin Lab India Conference is designed to have multiple conversations around the IVD Sector trends in both domestic and global markets.

Sub Themes for the Conference will address both Domestic and Global Markets unmet needs that Indian IVD Sector would be catering to.

Sub Theme – DOMESTIC MARKET :

Bridging the Diagnostic Divide by empowering rural India through Emerging, Innovative IVD Technologies, by fostering public-private partnerships for improved rural healthcare delivery .

Sub Theme – GLOBAL MARKET :

Democratizing Diagnostics focuses on innovative IVD strategies for underserved populations worldwide by adapting emerging, innovative,  versatile, low-cost IVD technologies and establishing international collaborations to enhance diagnostic access globally.

Conference Chairs

Chairman’s Invite

𝗪𝗵𝗼 𝗦𝗵𝗼𝘂𝗹𝗱 𝗔𝘁𝘁𝗲𝗻𝗱 ?

• IVD , Biotech companies – Management & Technical Personnel
• Healthcare Services – Management & Technical Teams from Clinical Labs/Hospitals/Blood Banks/CROs/Medical Colleges/Home Healthcare Companies and Other Healthcare Organisations
• Academia – Startups, Innovators from Medical Devices, IVD, Biotech space
• Government Representatives
• Consultants, Regulatory Affairs, EXIM , Legal Professionals, Technical Experts
• Other stakeholders

Benefits of Attending :

The “CLINLAB India 2025” conference, with its theme “Democratizing Diagnostics: The Domestic Vs Global Conundrum,” is poised to be a pivotal event for IVD sector stakeholders, biotech companies, and healthcare professionals. Here’s why:

Key Benefits for Stakeholders:

• Global Perspective: The conference offers a global perspective on the IVD industry, showcasing innovative low-cost IVD technologies and strategies for underserved populations worldwide. This is particularly beneficial for stakeholders looking to expand their reach and impact on a global scale.
• Emerging Technologies: Participants can learn about emerging technologies that are redefining diagnostics, such as telemedicine integration. This insight is crucial for stakeholders who want to stay ahead of the curve in this rapidly evolving industry.
• Quality and Safety: The conference emphasizes the importance of aligning with international quality and safety regulations, testing, and certifications. This focus on global standards is essential for stakeholders who want to ensure the highest quality and safety in their products and services.
• India’s IVD Manufacturing: The conference highlights India’s IVD manufacturing capabilities, showcasing the country’s potential to become a major player in the global IVD market. This focus on India’s IVD sector is crucial for stakeholders who want to tap into this growing market.
• Affordable Diagnostics: The conference addresses the critical issue of affordable diagnostics, particularly in the context of the Indian IVD market. This focus on affordability is crucial for stakeholders who want to make diagnostics more accessible to underserved populations.

In conclusion, stakeholders in the IVD sector, biotech companies, and healthcare professionals should attend the “CLINLAB India 2025” conference to stay informed about the latest trends and developments in the industry, network with other professionals, and contribute to the advancement of the IVD sector.

𝗗𝗲𝗹𝗲𝗴𝗮𝘁𝗲 𝗥𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 :

𝗗𝗲𝗹𝗲𝗴𝗮𝘁𝗶𝗼𝗻 𝗙𝗲𝗲: INR 1100 (including GST) per person

Fee includes Lunch & Hi Tea

𝗥𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗣𝗿𝗼𝗰𝗲𝘀𝘀 :

Step 1:

Scan here to make the payment

Step 2 :

Scan the QR Code to register for the conference

After the registration is done, pls send the payment screenshot , Reference / UTR number by mail to the below mentioned contact person for confirmation.

Alternatively, click on the button below to register yourself as a delegate :

Business Enquiries:

For enquiries related to Delegate Registration and other information to the Conference, please write to :

Ms Rama Venugopal
Vice Chairperson – CLIN LAB India Conference
Email – info@knowledge-healthcare.events

For enquiries related to Conference Partnerships, Stall bookings in the Expo, enquiries, please write to :

Adarsh Verma
VermaA@md-india.com 
+91-124-4544507

Share the page :

• Facebook
• LinkedIn
• X
• WhatsApp